Protein Misfolding Diseases and Neurodegeneration: From Experimental Approach to Clinical Therapy 'Current State of Biomarkers for the Early Detection of Alzheimer’s Disease'

---

RSSWEBINARDHPAMA

Wednesday, June 21, 2023, 5:00 PM - 6:15 PM, Livestreamed

The series will enable the audience to understand the mechanism of protein misfolding and amyloid formation behind the most common neurodegenerative diseases across the world and learn about the most recent advancements in their potential treatment modalities to promote a better understanding of the healthcare management options now and in the future.

Click on the session title above for more details.

To be able to register for the activity you MUST first Sign In to the portal.

The registration closes ONE day before the activity. You will receive a UNIQUE link to join the webinar on the day of the presentation.

1. 1- Recognize and list the latest developments in the field of diagnosis and treatment of neurodegenerative diseases
2. 2- Recognize the current state of biomarkers for the early detection of Alzheimer’s disease

Registration / Session: 12 USD ( 40 QAR )

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to [email protected].

Changes or Cancellations

• Name changes or substitutions are not permitted.
• All cancellation and refund requests must be made in writing and submitted via email to [email protected].
• For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
• We will attempt to process the refund within 30 days of receiving any cancellation request.
• Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.25 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

 

 Faculty: Michael Scholl, MD, has disclosed the following relationships: Membership on Advisory Committees or Review Panels, Board Membership, etc. - NovoNordisk and Roche; WILL NOT BE DISCUSSING unlabeled/unapproved use of drugs or products.

Administrative Contact: Safia Rabia has no relevant financial relationships to disclose and WILL NOT BE DISCUSSING unlabeled/unapproved use of drugs or products.

 

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.